Determination of Pediatric Osteogenesis Imperfecta Bone Material Properties
Determination of Pediatric Osteogenesis Imperfecta Bone Material Properties
批准号:
9808982
负责人:
JESSICA M FRITZ
金额:
$7.65万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
已结题
起止时间:
2019-08-01 至 2020-07-31
关键词:
AffectAgeBehaviorBiopsyBone DensityBone DiseasesBone TissueCaringChicagoChildChildhoodClinicalClinical DataClinical TreatmentClinical assessmentsCollagen Type IComplexDNA Sequence AlterationDataDevelopmentDiseaseEffectivenessElementsEngineeringEtiologyFailureFemoral FracturesFemurFinite Element AnalysisFractureGoalsHeritabilityImage AnalysisIncidenceIndividualLinkLocationLower Extremity FractureMeasuresMechanicsMethodologyMethodsModelingModulusOperative Surgical ProceduresOrthopedicsOsteogenesis ImperfectaOsteotomyPatientsPorosityPreventionPrevention approachProductionPropertyProteinsRare DiseasesRisk AssessmentSamplingSeveritiesSpecimenStressStructureTechniquesTestingUnited States National Institutes of HealthValidationWorkX-Ray Computed Tomographybasebonebone fragilitybone imagingbone massbone strengthclinical decision-makingcomputerized toolscortical bonefracture risklong bonemechanical propertiesmicroCTnanoindentationnovel strategiesreconstructiontibiatooltreatment planning
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY/ABSTRACT
Osteogenesis imperfecta (OI) is the most frequent heritable bone fragility disorder in children and is most
commonly caused by genetic mutations affecting type I collagen production, which is the primary protein of
bones. OI is common in pediatric orthopaedic centers, as affected individuals frequently require orthopaedic care
during their growing years. Long bone fracture is common in children with OI. Bone strength assessment is
critical in evaluating the effectiveness of current and new preventions and treatments of fractures in OI. Clinical
decision-making could be put on a firmer basis if there was a more objective, quantitative way to assess a bone's
capacity to withstand loading. The goal of the present project is to develop a micro-FE model of OI bone mini
beams and a model to predict strength from clinical bone mineral density data. Very little data is yet available to
describe bone material properties in OI. The first characterization studies of OI bone done by our team used
nanoindentation to measure elastic moduli at the microstructural scale in small biopsies or surgical specimens
of OI bones. Within that scale, the elastic modulus of bone tissues was found to be higher in children with severe
OI vs age-matched controls, and to be slightly higher in children with mild vs severe OI. Our team developed a
methodology using larger specimens of OI cortical bone. Using this technique, it was found that OI diaphyseal
specimens had reduced material strength compared to normal pediatric bone. In addition, our team also imaged
bone mini beams using micro-computed tomography (micro-CT). This allowed for the examination of cortical
bone porosity. Imaging analyses provide microstructural detail that would otherwise be unknown. This data
contributes to our knowledge of bone strength and fracture risk. A more detailed method for assessing bone
strength is finite element analysis (FEA), a computational tool widely used in engineering to evaluate stresses
and strains (i.e., internal local loading and deformation) within a complex structure by dividing it into smaller,
simpler parts (elements). Using patient-specific geometric information and accurate mechanical properties of OI
bone, FEA can simulate the behavior of long bones and assess fracture risk. The study PI has previously
assessed femur fracture risk in OI by using approximate reconstruction methods to create bowing in the femur
along with estimated OI bone tissue properties. This work also showed increased fracture risks with increased
bowing as well as increased OI severity. However, this model cannot be validated as that would require knowing
the exact force magnitude and location required to break the femur. Developing micro-FE models of the OI bone
specimen mini beams will provide the first validation of OI bone strength modeling and answer questions about
relationships between microstructure, macrostructure, vBMD, clinical data and whole bone strength.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Determination of Pediatric Osteogenesis Imperfecta Bone Material Properties
-
批准号:10217432
-
项目类别:
-
资助金额:$6.3万
-
财政年份:2020
-
负责人:JESSICA M FRITZ
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: